On the ISS this week June 23 - 27, 2025
When you buy through links on our articles, Future and its syndication partners may earn a commission.
They have arrived! After an extended delay, the Axiom Mission-4 (Ax-4) crew flying aboard SpaceX's Crew Dragon "Grace" pulled up to the International Space Station and docked, beginning a two-week stay on the orbiting laboratory. Meanwhile, science and maintenance work continued this week for the Expedition 73 crew.
In space, what goes up ... doesn't really matter to our brains.
"I think one of the most surprising or unexpected things is just how quickly your brain figures out that up and down doesn't really matter," said Nichole Ayers, Expedition 73 flight engineer, answering one of the questions the young students at P.S. 71 Forest Elementary School in Ridgewood, New York on Monday (June 23). "You know, on Earth, we've got gravity, and it pulls us down, and so we know where the floor is, but here on the space station, somebody could be upside down, and you could be talking to them like normal."
It was at this point in the video downlink that fellow NASA astronaut Anne McClain flipped upside down (in relation to Ayers' orientation).
"You know, our treadmill is on the wall, so is our lifting machine. And so it's pretty often that you turn around the corner and someone is not exactly like you would expect them to be, but your brain, after a couple weeks, just kind of goes, 'Okay, we can do this.' And you figure out that you can go through a module upside down, you can go through a module doing multiple aileron rolls, and your body is totally okay with that."
Among the research that was conducted by the Expedition 73 crew aboard the space station this week was:
Thigh Cuff — Expedition 73 commander Takuya Onishi and flight engineer Jonny Kim took turns wearing tight cuff on their legs in an effort to change the direction of the fluids in their body. In the weightless environment in space, fluids tend to pool up in the head, which can have negative effects. The two astronauts, working inside the European Columbus Laboratory, used an ultrasound device to monitor the effectiveness of the cuff.
Ring Sheared Drop — Continuing a multi-week fluids physics experiment, Nichole Ayers worked with an apparatus mounted inside a microgravity glove box in the U.S. Destiny Laboratory to see if surface tension can be used to isolate liquids from their containers' walls. The research could lead to advancements in formulating pharmaceuticals, among other applications.
Bio-Analyzer — Anne McClain activated this device, which allows for the on-orbit qualification of cellular and molecular samples collected aboard the space station.
Roscosmos cosmonauts Sergey Ryzhikov and Alexey Zubritskiy measured the flow through their large and small blood vessels, while Kirill Peskov checked the radiation levels on board the space station.
The Expedition 73 crew also devoted time to maintaining the space station's systems, including:
Day in the Life — Onishi, Kim and Ayers filmed training videos for future station crew members. They showed where spacesuits and EVA tools are stored in the Quest airlock, where safety equipment is located in the Harmony, Kibo and Columbus modules and typical crew activities in the Tranquility module, Cupola and Leonardo permanent multipurpose module (PMM).
Stowage space — Speaking of the PMM, McClain and Onishi rearranged cargo in the station's "storage closet," with the aim of making more room for more items to be moved inside. They then documented their work in photos for Mission Control to analyze.
Ryzhikov worked on the Russian segment's Elektron oxygen generator and Zubritskiy swapped out ventilation dust filters.
And then there were 11.
The Axiom Mission-4 crew arrived at the International Space Station on Thursday, June 26, 2025. Commander Peggy Whitson, pilot Shubhanshu Shukla of the Indian Space Research Organization (ISRO) and mission specialists Sławosz Uznański-Wiśniewski of the European Space Agency (ESA) and Tibor Kapu of the Hungarian to Orbit (HUNOR) astronaut program have joined the Expedition 73 for a two-week stay.
The international Ax-4 crew will set a record for the most research conducted on an Axiom Space mission to date. They have with them more than 60 experiments and technology demos from 31 countries, including the crew members' nations, as well as Saudi Arabia, Brazil, Nigeria and the United Arab Emirates.
The fourth commercial mission to the International Space Station as organized by Houston-based Axiom Space saw the arrival of the first citizens of India, Poland and Hungary aboard the orbiting outpost.
Led by Peggy Whitson, a former NASA astronaut who holds the record for the most time in space by an American (and a woman worldwide), Shubhanshu "Shux" Shukla, Sławosz "Suave" Uznański-Wiśniewski and Tibor Kapu spent their first couple of days becoming familiar with the layout of the station after docking on Thursday (June 26).
With the seven members of Expedition 73 already taking up the established sleep stations, the Ax-4 crew have set up camp where space was available: Whitson in the Quest airlock, Shukla in Dragon, Uznański-Wiśniewski in Columbus and Kapu in Kibo.
As of Friday (June 27), there are 11 people aboard the International Space Station: Expedition 73 commander Takuya Onishi of JAXA, Anne McClain, Nichole Ayers and Jonny Kim of NASA and Kirill Peskov, Sergey Ryzhikov and Alexey Zubritsky of Roscosmos, all flight engineers, as well as Axiom Mission 4 (Ax-4) commander Peggy Whitson, pilot Shubhanshu Shukla of the Indian Space Research Organization (ISRO) and mission specialists Sławosz Uznański-Wiśniewski of the European Space Agency (ESA) and Tibor Kapu of the Hungarian to Orbit (HUNOR) astronaut program.
There are three docked crew spacecraft: SpaceX's Dragon "Endurance" attached to the forward port of the Harmony module, Dragon "Grace" on the space-facing port of Harmony and Roscosmos' Soyuz MS-27 attached to the Earth-facing port of the Prichal node.
There are also two docked cargo spacecraft: Roscosmos' Progess MS-29 (90P) attached to the space-facing port of the Poisk module and Progress MS-30 (91P) attached to the aft port of the Zvezda service module.
As of Friday, the space station has been continuously crewed for 24 years, 7 months and 26 days.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
West Nile Virus found in mosquitoes in Lubbock County, warns city. Here's what to know
The City of Lubbock is warning Lubbock County residents that West Nile Virus has been detected in mosquitoes in the county. According to the city, the Biological Threat Research Lab at Texas Tech University has notified the Lubbock Health Department that mosquitoes carrying West Nile Virus are active in Lubbock County. Others are reading: What's coming in Lubbock County's proposed budget? Here's what's being discussed In response, the vector control teams will increase spraying within the community, with the city strongly urging the public to take precautions to reduce mosquito bites and help prevent the spread of the virus. The city is also asking residents to help prevent the spread of the virus by reporting biting adult mosquitoes or reporting a suspected mosquito breeding site. According to the health department, West Nile is a disease of birds that humans are exposed to after a mosquito has fed on an infected bird. Humans can only contract it from mosquitoes and cannot pass it to other humans. For more information about West Nile Virus, visit the CDC website: According to the health department, here are the common symptoms: Headache. Fever. Muscle and joint aches. Nausea. Fatigue. Symptoms involving the central nervous system can also develop, which include neck stiffness, stupor, disorientation, coma, tremors, convulsions, muscle weakness, and paralysis. According to the health department, most infected people show no symptoms, with most recovering on their own. Currently, there are no medications or vaccines to prevent or treat infection. People over 50 years old and those with other health issues are at a higher risk of becoming seriously ill. If people have symptoms and suspect West Nile Virus infection, they should contact their healthcare provider. Individuals can take the following steps to prevent infection this holiday week and throughout summer: Wearing an EPA-registered insect repellant Covering up with long-sleeved shirts and long pants Keeping mosquitoes out of living areas by using air conditioning or intact window screens Limiting outdoor activities during peak mosquito times Dumping standing water around your home As of June 18, there have been no reported human West Nile infection cases or deaths in Lubbock in 2025. Mateo Rosiles is the Government & Public Policy reporter for the Lubbock Avalanche-Journal. Got a news tip for him? Email him: mrosiles@ This article originally appeared on Lubbock Avalanche-Journal: West Nile Virus found in mosquitoes around Lubbock, city urges caution
Yahoo
33 minutes ago
- Yahoo
Sana Biotechnology (SANA) Stock Surges on Positive Type 1 Diabetes Treatment Results
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the 10 best healthcare penny stocks to buy according to analysts. The company's stock surged 12.1% on June 23 after it announced positive six-month follow-up results from an investigator-sponsored, first-in-human study of its type 1 diabetes treatment. A laboratory cultivating cells for the development of gene and cell therapies. The therapy in focus is UP421, which consists of cadaver-sourced pancreatic islet cells that have been genetically modified using Sana's hypoimmune (HIP) technology to evade immune detection. A significant finding is that the transplanted cells were safe, well-tolerated, survived, and continued to produce insulin in the patient without the need for immunosuppressive medicines. The study identified no safety issues, and the HIP-modified islet cells successfully evaded immune responses (both allogeneic and autoimmune). Per-Ola Carlsson, MD, Study Principal Investigator, Senior Physician, and Professor at the Clinic for Uppsala University Hospital, stated that the consistent results at four-week, 12-week, and now six-month follow-ups continue to suggest that a functional cure for type 1 diabetes without immunosuppression is possible. Sana Biotechnology, Inc. (NASDAQ:SANA) is a biotechnology company. It develops engineered cell therapies to treat serious diseases, aiming to repair or replace damaged cells. Its platforms include hypoimmune cells, gene delivery, and in vivo cell engineering. Sana's pipeline targets conditions like cancer, type 1 diabetes, and genetic disorders. While we acknowledge the potential of SANA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Goldman Sachs Energy Stocks: 10 Stocks to Buy and 10 Best AI Stocks to Buy According to Billionaire David Tepper. Disclosure: None.


Fox News
36 minutes ago
- Fox News
Ancient 'pharaoh's curse' fungus shows promise in killing cancer cells
A potentially deadly fungus known as "pharaoh's curse fungus" could offer an unexpected path to fighting cancer, recent research shows. Scientists from the University of Pennsylvania modified molecules from the fungus — which is officially called Aspergillus flavus — to create a new compound and enhance its cancer-killing properties. "Fungi gave us penicillin," said Dr. Xue (Sherry) Gao, an associate professor at UPenn and leader of the study, in a press release. "These results show that many more medicines derived from natural products remain to be found." The findings were published in the journal Nature Chemical Biology. Aspergillus flavus is found in decaying leaves and compost, as well as on trees, plants and some crops, according to Mayo Clinic. While the fungus doesn't endanger most healthy people, it can cause respiratory issues for those who have weakened immune systems or are taking certain medications. Some of the more severe complications of the fungus can include bleeding in the lungs and life-threatening infections in the brain, heart and kidneys, Mayo Clinic stated. After archaeologists opened King Tut's tomb in the 1920s, multiple members of the excavation team died suddenly, fueling rumors of a "curse" upon those who dared interfere with the pharaoh's rest, according to the UPenn press release. Decades later, doctors hypothesized that fungal spores, which had been dormant for thousands of years, could have infected the team. In the 1970s, it happened again, the university stated. A dozen scientists entered another tomb, this time in Poland — and 10 died within a few weeks. Later investigations were said to reveal the presence of Aspergillus flavus in the tomb. Now, the same fungus linked to King Tut's tomb could have the capability to fight leukemia in a new form of cancer therapy. "There are a variety of compounds able to be produced by fungus," Gao told Fox News Digital. These compounds can be toxic to different cells, she noted, depending on the "biological management we are able to mitigate." The study aimed to find a specific kind of compound — ribosomally synthesized and post-translationally modified peptides, or "RiPPs" — within Aspergillus flavus, which was previously shown to be a good source. When this compound is able to enter cancer cells, Gao said, it may be able to stop their growth. "Cancer cells divide uncontrollably," Gao said in the release. "These compounds block the formation of microtubules, which are essential for cell division." When mixed with human cancer cells, two variants of the molecules within these RiPPS were found to have potent effects against leukemia cells, the researchers found. Another variant performed as well as two FDA-approved drugs that have been used for decades to treat leukemia (cytarabine and daunorubicin). Tiffany Troso-Sandoval, M.D., a medical oncologist and cancer care consultant based in New York, cautioned that this study, which was performed on cell cultures, is still in the very early stages. "It's still very far away from being applicable to use in humans with leukemia," Troso-Sandoval, who was not involved in the study, told Fox News Digital. Speaking about RiPPs, the doctor told Fox News Digital, "What they're referring to [in the study] is basically a rare type of bioactive molecule that they have isolated from this fungus." There are multiple subtypes of leukemia, Troso-Sandoval pointed out, including acute and chronic forms. "One treatment might not work on [another] type of leukemia," she noted. Further testing is needed to determine which subtypes may contain the active molecule. The compound explored in the study had little to no effect on breast, liver or lung cancer cells, the researchers noted. This suggests that its disruptive effects only work on certain types of cells, which will be an important consideration when developing medications. Looking ahead, the researchers plan to test the fungus' potential in animal models and, ultimately, human trials. Gao told Fox News Digital she is "excited about what nature can create and how it can benefit our society." For more Health articles, visit The study received support from the National Institutes of Health, the University of Pennsylvania, the Welch Foundation, the Houston Area Molecular Biophysics Program, the Cancer Prevention and Research Institute of Texas and the National Science Foundation.